Abstract |
Enterotoxigenic Escherichia coli (ETEC) is a common cause of diarrheal illness in the military, travelers, and children living in low- to middle-income countries. Increased antibiotic resistance, the absence of a licensed vaccine, and the lack of broadly practical therapeutics perpetuate the significant health and financial burden resulting from ETEC infection. A critical step in the evaluation of vaccines and therapeutics is preclinical screening in a relevant animal disease model that closely replicates human disease. We previously developed a diarrheal model of class 5a colonization factor (CF) CFA/I-expressing ETEC in the New World owl monkey species Aotus nancymaae using ETEC strain H10407. In order to broaden the use of the model, we report here on the development of A. nancymaae models of ETEC expressing the class 5b CFs CS17 and CS19 with strains LSN03-016011/A and WS0115A, respectively. For both models, we observed diarrheal attack rates of ≥80% after oral inoculation with 5 × 1011 CFU of bacteria. These models will aid in assessing the efficacy of future ETEC vaccine candidates and therapeutics.
|
Authors | Eric R Hall, Aisling O'Dowd, Julianne E Rollenhagen, Nereyda Espinoza, Gladys Nunez, Stephen J Savarino |
Journal | Infection and immunity
(Infect Immun)
Vol. 89
Issue 3
(02 16 2021)
ISSN: 1098-5522 [Electronic] United States |
PMID | 33288648
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
|
Chemical References |
- Enterotoxins
- Escherichia coli Vaccines
|
Topics |
- Animals
- Aotidae
(genetics, microbiology)
- Diarrhea
(drug therapy, microbiology)
- Disease Models, Animal
- Enterotoxigenic Escherichia coli
(genetics, pathogenicity)
- Enterotoxins
- Escherichia coli Infections
(drug therapy, prevention & control)
- Escherichia coli Vaccines
- Genes, Bacterial
|